slow responder to glp 1 Little Progress Is Still Progress: GLP-1 Journey Why GLP-1 Non-Responders Need Earlier

10.1016/j.peptides.2015.06.006 105 RichardsP.ParkerH

He encourages patients to approach their first dose with a plan including reviewing medical history, scheduling a consistent weekly time, and maintaining balanced nutrition and hydration

They work around it by improving insulin sensitivity while active, but the underlying cellular resistance often remains

2019 Esc guidelines on diabetes, pre-Diabetes, and cardiovascular diseases developed in collaboration with the easd

The first six amino acids of native GLP-1 are absent, and two key substitutions are introduced: at position 8, alanine is replaced by 2-aminoisobutyric acid (Aib) to prevent degradation by dipeptidyl peptidase-4 (DPP-4), and at position 34, lysine is replaced by arginine to improve stability

The evidence base for these medications, across metabolic, cardiovascular, and hepatic outcomes, is compelling and growing